Kopetz S, Tabernero J, Lonardi S, Shen L, et al. A randomised study of encorafenib, cetuximab, and FOLFIRI versus FOLFIRI with or without bevacizumab in BRAF V600E-mutant colorectal cancer: BREAKWATER Cohort 3. Ann Oncol 2026 May 31:S0923-7534(26)00179-1. doi: 10.1016/j.annonc.2026.
PMID: 42219860